Logo

Merck Animal Health to Acquire Rights to Sentinel Brand of Combination Parasiticides for Companion Animals in the US for $400M

Share this

Merck Animal Health to Acquire Rights to Sentinel Brand of Combination Parasiticides for Companion Animals in the US for $400M

Shots:

  • Merck Animal Health to acquire the US rights to Sentinel flavor tabs and chews in the companion animal category- under the agreement with Virbac. The transaction is expected to be closed by mid-2020
  • With the acquisition- Merck expects to provide veterinarians continuous parasite protection for dogs in easy to administer- palatable formulations
  • The products will target different parts of the flea lifecycle offering broad-spectrum- internal parasite protection in the Sentinel brand and the extended duration flea and tick protection of Bravecto

­ Ref: Merck Animal Health | Image: Merck 

Click here to­ read the full press release 

Senior Editor

This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions